S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HEXO Corp. stock logo
HEXO
HEXO
$0.71
+2.5%
$0.87
$0.66
$3.84
$31.24M1.35880,508 shs305,500 shs
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$4.89
-1.0%
C$4.22
C$3.34
C$7.12
C$156.09M1.1610,113 shs5,800 shs
Nexus Gold Corp. stock logo
NXS
Nexus Gold
C$0.02
+33.3%
C$0.02
C$0.02
C$0.10
C$837K0.8569,010 shs217,589 shs
Organigram Holdings Inc. stock logo
OGI
Organigram
$1.83
-2.7%
$2.11
$0.97
$2.91
$188.86M1.091.38 million shs1.43 million shs
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HEXO Corp. stock logo
HEXO
HEXO
0.00%0.00%0.00%0.00%-41.32%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.00%-4.68%+21.64%+16.15%-19.84%
Nexus Gold Corp. stock logo
NXS
Nexus Gold
+33.33%0.00%-20.00%+33.33%+300.00%
Organigram Holdings Inc. stock logo
OGI
Organigram
-2.66%-11.59%-17.94%+8.93%-15.28%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.0672 of 5 stars
1.10.01.70.00.90.80.0
Nexus Gold Corp. stock logo
NXS
Nexus Gold
N/AN/AN/AN/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
0.3057 of 5 stars
0.02.00.00.03.10.01.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
2.25
HoldC$4.58-6.44% Downside
Nexus Gold Corp. stock logo
NXS
Nexus Gold
N/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
3.00
BuyN/AN/A

Current Analyst Ratings

Latest OGI, HEXO, HLS, and NXS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Organigram Holdings Inc. stock logo
OGI
Organigram
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
3/18/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$6.50 ➝ C$5.00
3/15/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$4.35 ➝ C$4.15
2/22/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetC$5.00 ➝ C$4.35
2/6/2024
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
Clarus Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HEXO Corp. stock logo
HEXO
HEXO
$146.20M0.21N/AN/A$2.44 per share0.29
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$63.07M2.47C$0.32 per share15.22C$3.06 per share1.60
Nexus Gold Corp. stock logo
NXS
Nexus Gold
N/AN/AC$0.00 per share10.00C($0.01) per shareN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
$120.01M1.57N/AN/A$2.48 per share0.74

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HEXO Corp. stock logo
HEXO
HEXO
-$845.90M-$5.21N/AN/AN/A-235.33%-74.04%-32.51%N/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$27.53M-C$1.16N/AN/A-43.65%-24.69%-2.87%5/9/2024 (Estimated)
Nexus Gold Corp. stock logo
NXS
Nexus Gold
-C$1.92M-C$0.06N/AN/AN/A-1,307.50%-53.77%5/29/2024 (Estimated)
Organigram Holdings Inc. stock logo
OGI
Organigram
-$184.34M-$0.80N/AN/AN/A-173.48%-30.94%-27.70%4/23/2024 (Estimated)

Latest OGI, HEXO, HLS, and NXS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/14/2024Q4 2023
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
-C$0.13-C$0.18-C$0.05-C$0.13C$21.83 millionC$21.60 million
2/13/2024Q1 2024
Organigram Holdings Inc. stock logo
OGI
Organigram
-$0.10-$0.14-$0.04-$0.14$28.61 million$26.78 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
HEXO Corp. stock logo
HEXO
HEXO
N/AN/AN/AN/AN/A
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
C$0.204.09%N/AN/A N/A
Nexus Gold Corp. stock logo
NXS
Nexus Gold
N/AN/AN/AN/AN/A
Organigram Holdings Inc. stock logo
OGI
Organigram
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HEXO Corp. stock logo
HEXO
HEXO
0.01
0.41
0.24
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
89.69
1.65
1.01
Nexus Gold Corp. stock logo
NXS
Nexus Gold
14,120.33
0.05
0.38
Organigram Holdings Inc. stock logo
OGI
Organigram
N/A
4.28
2.11

Ownership

Institutional Ownership

CompanyInstitutional Ownership
HEXO Corp. stock logo
HEXO
HEXO
7.78%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
59.62%
Nexus Gold Corp. stock logo
NXS
Nexus Gold
N/A
Organigram Holdings Inc. stock logo
OGI
Organigram
34.63%

Insider Ownership

CompanyInsider Ownership
HEXO Corp. stock logo
HEXO
HEXO
4.69%
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
0.49%
Nexus Gold Corp. stock logo
NXS
Nexus Gold
0.51%
Organigram Holdings Inc. stock logo
OGI
Organigram
0.09%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
HEXO Corp. stock logo
HEXO
HEXO
1,27744.00 million41.93 millionOptionable
HLS Therapeutics Inc. stock logo
HLS
HLS Therapeutics
9131.92 millionN/ANot Optionable
Nexus Gold Corp. stock logo
NXS
Nexus Gold
N/A41.87 millionN/ANot Optionable
Organigram Holdings Inc. stock logo
OGI
Organigram
984103.20 million103.11 millionOptionable

OGI, HEXO, HLS, and NXS Headlines

SourceHeadline
Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"Organigram (NASDAQ:OGI) Upgraded by Alliance Global Partners to "Buy"
americanbankingnews.com - April 16 at 4:50 AM
Organigram (NASDAQ:OGI) Lifted to Buy at Alliance Global PartnersOrganigram (NASDAQ:OGI) Lifted to Buy at Alliance Global Partners
marketbeat.com - April 15 at 9:11 AM
Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)Analysts Are Bullish on These Healthcare Stocks: Tonix Pharma (TNXP), OrganiGram Holdings (OGI)
markets.businessinsider.com - April 11 at 1:36 PM
Organigram Recognized for Executive Gender Diversity by the Globe & Mails Women Lead Here Report for the Fourth Consecutive YearOrganigram Recognized for Executive Gender Diversity by the Globe & Mail's Women Lead Here Report for the Fourth Consecutive Year
stockhouse.com - April 10 at 5:10 PM
Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI)Q2 2024 EPS Estimates for Organigram Holdings Inc. Increased by Atb Cap Markets (NASDAQ:OGI)
marketbeat.com - April 5 at 8:21 AM
Organigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
finance.yahoo.com - April 3 at 8:37 AM
Organigrams Popular SHRED Brand Surpasses $200 Million in Yearly Retail SalesOrganigram's Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
businesswire.com - April 3 at 8:06 AM
Organigram Successfully Closes Previously Announced Underwritten Public OfferingOrganigram Successfully Closes Previously Announced Underwritten Public Offering
businesswire.com - April 2 at 8:51 AM
Organigram (NASDAQ:OGI) Stock Price Down 6.3%Organigram (NASDAQ:OGI) Stock Price Down 6.3%
marketbeat.com - March 30 at 12:43 AM
Why OrganiGram (OGI) Might Surprise This Earnings SeasonWhy OrganiGram (OGI) Might Surprise This Earnings Season
zacks.com - March 28 at 9:56 AM
Why OrganiGram (OGI) Stock Is DivingWhy OrganiGram (OGI) Stock Is Diving
msn.com - March 27 at 3:18 PM
Organigram Sells Units to Raise C$25 MIllionOrganigram Sells Units to Raise C$25 MIllion
newcannabisventures.com - March 27 at 10:18 AM
Organigram Announces Pricing of Overnight Marketed Public OfferingOrganigram Announces Pricing of Overnight Marketed Public Offering
businesswire.com - March 27 at 8:56 AM
Organigram Announces Launch of Overnight Marketed Public OfferingOrganigram Announces Launch of Overnight Marketed Public Offering
businesswire.com - March 26 at 7:06 PM
Organigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter InvestmentOrganigram Invests in U.S. Based Open Book Extracts Representing Inaugural Jupiter Investment
businesswire.com - March 26 at 1:36 PM
OGI Sep 2024 6.000 callOGI Sep 2024 6.000 call
finance.yahoo.com - March 26 at 12:10 AM
OGI Jun 2024 4.000 putOGI Jun 2024 4.000 put
finance.yahoo.com - March 26 at 12:10 AM
Organigram ‘assessing options’ after unfavorable ruling on cannabis ediblesOrganigram ‘assessing options’ after unfavorable ruling on cannabis edibles
mjbizdaily.com - March 26 at 12:10 AM
The Marijuana Stocks Could See A Rise This WeekThe Marijuana Stocks Could See A Rise This Week
marijuanastocks.com - March 24 at 9:40 AM
Organigram Receives Health Canadas Final Redetermination on JoltsOrganigram Receives Health Canada's Final Redetermination on Jolts
businesswire.com - March 22 at 7:00 PM
Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5Finding the Next Big Winners: 3 Stocks You Can Snag for Under $5
investorplace.com - March 21 at 4:05 PM
OGI Apr 2024 2.000 putOGI Apr 2024 2.000 put
finance.yahoo.com - March 17 at 12:08 AM
Top Marijuana Stocks For Trading Today 2024Top Marijuana Stocks For Trading Today 2024
marijuanastocks.com - March 6 at 9:06 AM
2 Top Marijuana Penny Stocks with High Momentum Before March 20242 Top Marijuana Penny Stocks with High Momentum Before March 2024
marijuanastocks.com - March 2 at 11:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

HEXO logo

HEXO

NYSE:HEXO
HEXO Corp., together with its subsidiaries, produces, markets, and sells cannabis in Canada. The company offers its adult-use and medical products under the HEXO brand name. It also provides cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brands; and cannabis products under UP Cannabis, Original Stash, and Up brand names. It has a strategic alliance with Tilray Brands, Inc. The company was formerly known as The Hydropothecary Corporation and changed its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Gatineau, Canada. As of June 22, 2023, HEXO Corp. operates as a subsidiary of Tilray Brands, Inc.
HLS Therapeutics logo

HLS Therapeutics

TSE:HLS
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease. schizophrenia. It also distributes MyCare psychiatry lab assays; and MyCare Insite, a point-of-care device to measure patient drug levels. In addition, the company holds the Canadian rights of Trinomia, a cardiovascular therapeutic; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. is headquartered in Etobicoke, Canada.
Nexus Gold logo

Nexus Gold

CVE:NXS
Nexus Gold Corp. engages in the exploration and evaluation of mineral properties in West Africa and Canada. The company explores for gold, silver, manganese, bauxite, copper, nickel, lead, zinc, and limestone/marble deposits. Its flagship property is the Bouboulou project located in Burkina Faso, West Africa. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.
Organigram logo

Organigram

NASDAQ:OGI
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as consumer channels. The company was incorporated in 2010 and is headquartered in Toronto, Canada.